Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig J Thomas

Showing results (81-90 of 237) with videos related to

Pageof 24
Sort By:
Plos One|August 25, 2016
Chemical Screens Identify Drugs that Enhance or Mitigate Cellular Responses to Antibody-Toxin Fusion ProteinsAntonella Antignani, Lesley Mathews Griner, Rajarshi Guha, et al.
Bioorganic & Medicinal Chemistry Letters|April 1, 2011
Potent and selective small molecule inhibitors of specific isoforms of Cdc2-like kinases (Clk) and dual specificity tyrosine-phosphorylation-regulated kinases (Dyrk)Andrew S Rosenthal, Cordelle Tanega, Min Shen, et al.
Plos One|April 3, 2020
A homogeneous SIRPα-CD47 cell-based, ligand-binding assay: Utility for small molecule drug development in immuno-oncologyTeresa L Burgess, Joshua D Amason, Jeffrey S Rubin, et al.
Physiological Reports|March 9, 2017
Inhibition of MAPK-Erk pathway in vivo attenuates aortic valve disease processes in Emilin1-deficient mouse modelCharu Munjal, Anil G Jegga, Amy M Opoka, et al.
Psychopharmacology|August 18, 2018
Plasma metabolomic profiling of a ketamine and placebo crossover trial of major depressive disorder and healthy control subjectsRuin Moaddel, Michelle Shardell, Mohammed Khadeer, et al.
Nucleic Acids Research|April 25, 2020
O-GlcNAc regulates gene expression by controlling detained intron splicingZhi-Wei Tan, George Fei, Joao A Paulo, et al.
Cell Metabolism|October 18, 2016
Environment Dictates Dependence on Mitochondrial Complex I for NAD+ and Aspartate Production and Determines Cancer Cell Sensitivity to MetforminDan Y Gui, Lucas B Sullivan, Alba Luengo, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 29, 2016
Behavioral, Neurophysiological, and Synaptic Impairment in a Transgenic Neuregulin1 (NRG1-IV) Murine Schizophrenia ModelFrancesco Papaleo, Feng Yang, Clare Paterson, et al.
The Journal of Biological Chemistry|February 21, 2006
A low molecular weight agonist signals by binding to the transmembrane domain of thyroid-stimulating hormone receptor (TSHR) and luteinizing hormone/chorionic gonadotropin receptor (LHCGR)Holger Jäschke, Susanne Neumann, Susanna Moore, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 2019
(<i>2R,6R</i>)-hydroxynorketamine exerts mGlu<sub>2</sub> receptor-dependent antidepressant actionsPanos Zanos, Jaclyn N Highland, Brent W Stewart, et al.
Pageof 24

Showing results (81-90 of 237) with videos related to

Sort By:
Pageof 24
Plos One|August 25, 2016
Chemical Screens Identify Drugs that Enhance or Mitigate Cellular Responses to Antibody-Toxin Fusion ProteinsAntonella Antignani, Lesley Mathews Griner, Rajarshi Guha, et al.
Bioorganic & Medicinal Chemistry Letters|April 1, 2011
Potent and selective small molecule inhibitors of specific isoforms of Cdc2-like kinases (Clk) and dual specificity tyrosine-phosphorylation-regulated kinases (Dyrk)Andrew S Rosenthal, Cordelle Tanega, Min Shen, et al.
Plos One|April 3, 2020
A homogeneous SIRPα-CD47 cell-based, ligand-binding assay: Utility for small molecule drug development in immuno-oncologyTeresa L Burgess, Joshua D Amason, Jeffrey S Rubin, et al.
Physiological Reports|March 9, 2017
Inhibition of MAPK-Erk pathway in vivo attenuates aortic valve disease processes in Emilin1-deficient mouse modelCharu Munjal, Anil G Jegga, Amy M Opoka, et al.
Psychopharmacology|August 18, 2018
Plasma metabolomic profiling of a ketamine and placebo crossover trial of major depressive disorder and healthy control subjectsRuin Moaddel, Michelle Shardell, Mohammed Khadeer, et al.
Nucleic Acids Research|April 25, 2020
O-GlcNAc regulates gene expression by controlling detained intron splicingZhi-Wei Tan, George Fei, Joao A Paulo, et al.
Cell Metabolism|October 18, 2016
Environment Dictates Dependence on Mitochondrial Complex I for NAD+ and Aspartate Production and Determines Cancer Cell Sensitivity to MetforminDan Y Gui, Lucas B Sullivan, Alba Luengo, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 29, 2016
Behavioral, Neurophysiological, and Synaptic Impairment in a Transgenic Neuregulin1 (NRG1-IV) Murine Schizophrenia ModelFrancesco Papaleo, Feng Yang, Clare Paterson, et al.
The Journal of Biological Chemistry|February 21, 2006
A low molecular weight agonist signals by binding to the transmembrane domain of thyroid-stimulating hormone receptor (TSHR) and luteinizing hormone/chorionic gonadotropin receptor (LHCGR)Holger Jäschke, Susanne Neumann, Susanna Moore, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 2019
(<i>2R,6R</i>)-hydroxynorketamine exerts mGlu<sub>2</sub> receptor-dependent antidepressant actionsPanos Zanos, Jaclyn N Highland, Brent W Stewart, et al.
Pageof 24